Bjarni E Pjetursson1,2, Nicola A Valente2, Malin Strasding2, Marcel Zwahlen3, Shiming Liu2,4, Irena Sailer2. 1. Department of Reconstructive Dentistry, Faculty of Odontology, University of Iceland, Reykjavik, Iceland. 2. Division of Fixed Prosthodontics and Biomaterials, University Clinics for Dental Medicine, University of Geneva, Geneva, Switzerland. 3. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. 4. Department of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Abstract
OBJECTIVES: The aim of the present systematic review was to analyze the survival and complication rates of zirconia-based and metal-ceramic implant-supported single crowns (SCs). MATERIALS AND METHODS: An electronic MEDLINE search complemented by manual searching was conducted to identify randomized controlled clinical trials, prospective cohort and retrospective case series on implant-supported SCs with a mean follow-up time of at least 3 years. Patients had to have been clinically examined at the follow-up visit. Assessment of the identified studies and data extraction was performed independently by two reviewers. Failure and complication rates were analyzed using robust Poisson's regression models to obtain summary estimates of 5-year proportions. RESULTS: The search provided 5,263 titles and 455 abstracts, full-text analysis was performed for 240 articles, resulting in 35 included studies on implant-supported crowns. Meta-analysis revealed an estimated 5-year survival rate of 98.3% (95% CI: 96.8-99.1) for metal-ceramic implant supported SCs (n = 4,363) compared to 97.6% (95% CI: 94.3-99.0) for zirconia implant supported SCs (n = 912). About 86.7% (95% CI: 80.7-91.0) of the metal-ceramic SCs (n = 1,300) experienced no biological/technical complications over the entire observation period. The corresponding rate for zirconia SCs (n = 76) was 83.8% (95% CI: 61.6-93.8). The biologic outcomes of the two types of crowns were similar; yet, zirconia SCs exhibited less aesthetic complications than metal-ceramics. The 5-year incidence of chipping of the veneering ceramic was similar between the material groups (2.9% metal-ceramic, 2.8% zirconia-ceramic). Significantly (p = 0.001), more zirconia-ceramic implant SCs failed due to material fractures (2.1% vs. 0.2% metal-ceramic implant SCs). No studies on newer types of monolithic zirconia SCs fulfilled the simple inclusion criteria of 3 years follow-up time and clinical examination of the present systematic review. CONCLUSION: Zirconia-ceramic implant-supported SCs are a valid treatment alternative to metal-ceramic SCs, with similar incidence of biological complications and less aesthetic problems. The amount of ceramic chipping was similar between the material groups; yet, significantly more zirconia crowns failed due to material fractures.
OBJECTIVES: The aim of the present systematic review was to analyze the survival and complication rates of zirconia-based and metal-ceramic implant-supported single crowns (SCs). MATERIALS AND METHODS: An electronic MEDLINE search complemented by manual searching was conducted to identify randomized controlled clinical trials, prospective cohort and retrospective case series on implant-supported SCs with a mean follow-up time of at least 3 years. Patients had to have been clinically examined at the follow-up visit. Assessment of the identified studies and data extraction was performed independently by two reviewers. Failure and complication rates were analyzed using robust Poisson's regression models to obtain summary estimates of 5-year proportions. RESULTS: The search provided 5,263 titles and 455 abstracts, full-text analysis was performed for 240 articles, resulting in 35 included studies on implant-supported crowns. Meta-analysis revealed an estimated 5-year survival rate of 98.3% (95% CI: 96.8-99.1) for metal-ceramic implant supported SCs (n = 4,363) compared to 97.6% (95% CI: 94.3-99.0) for zirconia implant supported SCs (n = 912). About 86.7% (95% CI: 80.7-91.0) of the metal-ceramic SCs (n = 1,300) experienced no biological/technical complications over the entire observation period. The corresponding rate for zirconia SCs (n = 76) was 83.8% (95% CI: 61.6-93.8). The biologic outcomes of the two types of crowns were similar; yet, zirconia SCs exhibited less aesthetic complications than metal-ceramics. The 5-year incidence of chipping of the veneering ceramic was similar between the material groups (2.9% metal-ceramic, 2.8% zirconia-ceramic). Significantly (p = 0.001), more zirconia-ceramic implant SCs failed due to material fractures (2.1% vs. 0.2% metal-ceramic implant SCs). No studies on newer types of monolithic zirconia SCs fulfilled the simple inclusion criteria of 3 years follow-up time and clinical examination of the present systematic review. CONCLUSION:Zirconia-ceramic implant-supported SCs are a valid treatment alternative to metal-ceramic SCs, with similar incidence of biological complications and less aesthetic problems. The amount of ceramic chipping was similar between the material groups; yet, significantly more zirconia crowns failed due to material fractures.
Authors: Pedro Molinero-Mourelle; Rocio Cascos-Sanchez; Burak Yilmaz; Walter Yu Hang Lam; Edmond Ho Nang Pow; Jaime Del Río Highsmith; Miguel Gómez-Polo Journal: Materials (Basel) Date: 2021-04-30 Impact factor: 3.623
Authors: John J Mecholsky; Shu-Min Hsu; Osama Jadaan; Jason Griggs; Daniel Neal; Arthur E Clark; Xinyi Xia; Josephine F Esquivel-Upshaw Journal: J Biomed Mater Res B Appl Biomater Date: 2021-02-01 Impact factor: 3.405
Authors: Babak Saravi; Andreas Vollmer; Maja Hartmann; Gernot Lang; Ralf-Joachim Kohal; Martin Boeker; Sebastian B M Patzelt Journal: Materials (Basel) Date: 2021-05-20 Impact factor: 3.623
Authors: Paolo De Angelis; Giulio Gasparini; Francesca Camodeca; Silvio De Angelis; Margherita Giorgia Liguori; Edoardo Rella; Francesca Cannata; Antonio D'Addona; Paolo Francesco Manicone Journal: Biomed Res Int Date: 2021-07-06 Impact factor: 3.411
Authors: Edmara T P Bergamo; Everardo N S de Araújo-Júnior; Adolfo C O Lopes; Paulo G Coelho; Abbas Zahoui; Ernesto B Benalcázar Jalkh; Estevam A Bonfante Journal: Biomed Res Int Date: 2020-09-07 Impact factor: 3.411